- Home
- BRTX vs IMNN Comparison
BRTX vs IMNN Comparison
Compare BRTX & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- IMNN
- Stock Information
- Founded
- BRTX 1997
- IMNN 1982
- Country
- BRTX United States
- IMNN United States
- Employees
- BRTX N/A
- IMNN N/A
- Industry
- BRTX Managed Health Care
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- BRTX Health Care
- IMNN Health Care
- Exchange
- BRTX Nasdaq
- IMNN Nasdaq
- Market Cap
- BRTX 10.7M
- IMNN 13.6M
- IPO Year
- BRTX N/A
- IMNN 1985
- Fundamental
- Price
- BRTX $1.58
- IMNN $0.85
- Analyst Decision
- BRTX Strong Buy
- IMNN Strong Buy
- Analyst Count
- BRTX 1
- IMNN 2
- Target Price
- BRTX $18.00
- IMNN $20.50
- AVG Volume (30 Days)
- BRTX 1.1M
- IMNN 140.7K
- Earning Date
- BRTX 03-28-2025
- IMNN 02-27-2025
- Dividend Yield
- BRTX N/A
- IMNN N/A
- EPS Growth
- BRTX N/A
- IMNN N/A
- EPS
- BRTX N/A
- IMNN N/A
- Revenue
- BRTX $377,000.00
- IMNN N/A
- Revenue This Year
- BRTX $482.76
- IMNN N/A
- Revenue Next Year
- BRTX $212.24
- IMNN N/A
- P/E Ratio
- BRTX N/A
- IMNN N/A
- Revenue Growth
- BRTX 189.55
- IMNN N/A
- 52 Week Low
- BRTX $1.03
- IMNN $0.64
- 52 Week High
- BRTX $2.55
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- BRTX 41.43
- IMNN 51.32
- Support Level
- BRTX $1.46
- IMNN $0.86
- Resistance Level
- BRTX $1.68
- IMNN $0.93
- Average True Range (ATR)
- BRTX 0.22
- IMNN 0.05
- MACD
- BRTX -0.01
- IMNN 0.00
- Stochastic Oscillator
- BRTX 25.81
- IMNN 68.81
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About IMNN Imunon Inc.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.